LifeVantage
Corporation (OTCBB: LFVN), the maker ofProtandim®,
the only product clinically proven to slow the progressive rate of
aging, today announced that the senior management team has been invited
to present at the upcoming EdgeWater
Research Fall 2008 Small/Micro Cap Conference to be held in Coeur d'
Alene, Idaho, on September 24th and 25th,
2008.
LifeVantage was featured in the August edition of The EdgeWater Micro
Monthly, in which the editor David Lavigne wrote, "They
have in a few months restructured a number of things (distribution -
both domestic and international, etc.), embarked on adding some new
product lines, skin care for example, which I think has enormous
potential, and have begun to lay the ground work for entrees into other
verticals, veterinary might be an example."
David Brown, LifeVantage President and CEO, said, "LifeVantage
is pleased to be invited to present at the well-known EdgeWater Research
Conference. This is an excellent opportunity to share the LifeVantage
story with members of the financial community who are active in the
Small/Micro Cap markets. LifeVantage has recently increased sales
distribution, as well as its on-line presence, and has made great
progress in improving overall brand awareness. Our branding efforts,
together with the many scientific studies underway nationwide at leading
universities and research institutes to study the effect of Protandim on
various diseases and health conditions, should generate greater interest
in the Company."
About EdgeWater Research
Partners, LLC
EdgeWater Research Partners, LLC is an independent micro cap equities
research company representing the research of David Lavigne. EdgeWater
follows a number of undiscovered small and micro cap stocks through both
individual research and its monthly publication, The EdgeWater Micro
Monthly. EdgeWater's research is distributed to its subscriber base,
and is also available on a piece by piece basis on the Company's
website, http://www.edgewaterresearch.com.
About Protandim®
Protandim® is a
groundbreaking, clinically proven solution for healthy aging. This
patented anti-oxidant therapy is 1000's of
times more powerful than red wine, oranges, blueberries, acai juice or
other popular anti-oxidant supplements. Protandim works by increasing
the body's natural anti-oxidant protection at
the cellular level, triggering cells to produce naturally occurring
protective antioxidant enzymes such as super oxide dismutase (SOD),
catalase, and glutathione.
A peer-reviewed scientific study shows that after 30 days of taking
Protandim, free radicals decreased an average of 40 percent, slowing the
progressive aging factors to the level of a 20 year old. Protandim is
currently the subject of over 20 scientific studies at leading
universities and research institutes. For more information, please visit
the Protandim® product web site at www.protandim.com
or contact Jan Strode at 619-890-4040.
About
LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB: LFVN),
science-based, natural products company, dedicated to helping people
reach their health and wellness goals through science-based solutions to
oxidative stress. Founded in 2003 and based in Colorado, LifeVantage
develops nutraceutical products, including Protandim,
that leverage the company's expertise and that are intended to deliver
significant health benefits to consumers. For more information, visit www.lifevantage.com
or contact Jan Strode at 619-890-4040.
This document contains forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995.The Company uses the words "anticipate,""believe,""could,""should,""estimate,""expect,""intend,""may,""predict,""project,""plan,""target" and
similar terms and phrases, including references to assumptions, to
identify forward-looking statements.These forward-looking
statements are based on the Company's current
expectations and beliefs concerning future events affecting the Company
and involve known and unknown risks and uncertainties that may cause the
Company's actual results or outcomes to be materially different from
those anticipated and discussed herein.These risks and
uncertainties include, among others, the risk that government regulators
and regulations could adversely affect our business; future laws or
regulations may hinder or prohibit the production or sale of our
existing product and any future products; unfavorable publicity could
materially hurt our business; and the Company's
ability to protect our intellectual property rights and the value of our
product.These and other risk factors are discussed in greater
detail in the Company's Annual Report on Form
10-KSB under the caption "Risk Factors",
and in other documents filed by the Company from time to time with the
Securities and Exchange Commission.The Company cautions
investors not to place undue reliance on the forward-looking statements
contained in this document.All forward-looking statements are
based on information currently available to the Company on the date
hereof, and the Company undertakes no obligation to revise or update
these forward-looking statements to reflect events or circumstances
after the date of this document, except as required by law.
*These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
Note to Editors: Contact Jan Strode at 619-890-4040 for interviews,
photography, and other requests.
LifeVantage Corporation
Jan Strode, 619-890-4040
Jean Golden,
612-385-2324